ConductScience.org, home

Paper11278747

Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice.

Liu CH and 8 others. J Biol Chem, 2001. Cited by 688 papers, by iCite.

Cite this record

ConductScience Library. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. Papers, record 11278747. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11278747

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice.
PubMed
Journal
J Biol Chem
PubMed
Year
2001
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
688
iCite
Relative citation ratio, by iCite
14.9
iCite
Revised in PubMed
2022-04-08
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu CHC H
2Chang SHS H
3Narko KK
4Trifan OCO C
5Wu MTM T
6Smith EE
7Haudenschild CC
8Lane TFT F
9Hla TT

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
IsoenzymesMajor topic
Mammary Neoplasms, ExperimentalMajor topic
Prostaglandin-Endoperoxide SynthasesMajor topic
Animals
Cyclooxygenase 2
Female
Gene Expression Regulation, Enzymologic
Mice
Mice, Transgenic

Source PubMed

Download CSV of topics

Cited by231

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 688 citations.

PMIDTitleJournalYearIn PapersSource
41512995S-nitrosylated COX-2 is a microenvironment-regulated breast cancer cell biomarker of mesenchymal phenotypes.Exp Cell Res2026https://conductscience.org/library/papers/41512995PubMed
40691279Association between low-dose aspirin use and breast cancer recurrence: a Danish nationwide cohort study with up to 23 years of follow-up.Br J Cancer2025https://conductscience.org/library/papers/40691279PubMed
40542767Anti- Cancer Potential of Diosgenin, a Steroidal Saponin, against Human Oral Cancer Cells.Asian Pac J Cancer Prev2025https://conductscience.org/library/papers/40542767PubMed
40248271Expression of cyclooxygenase-2 (COX-2) in epithelial ovarian cancers in an Indigenous African population of Kano, Nigeria.Ecancermedicalscience2025https://conductscience.org/library/papers/40248271PubMed
39953784Benzo[a]phenoselenazine-based NIR photodynamic therapy for the treatment of COX-2 overexpressing cancer cells.Future Med Chem2025https://conductscience.org/library/papers/39953784PubMed
39830670Dual COX-2/TNF-α Inhibitors as Promising Anti-inflammatory and Cancer Chemopreventive Agents: A Review.Iran J Pharm Res2024https://conductscience.org/library/papers/39830670PubMed
39717807Repurposing of Indomethacin and Naproxen as anticancer agents: progress from 2017 to present.RSC Adv2024https://conductscience.org/library/papers/39717807PubMed
39652176Treatment of cancer-associated fibroblast-like cells with celecoxib enhances the anti-cancer T helper 1/Treg responses in breast cancer.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/39652176PubMed
38990306Celecoxib inhibits NLRP1 inflammasome pathway in MDA-MB-231 Cells.Naunyn Schmiedebergs Arch Pharmacol2024https://conductscience.org/library/papers/38990306PubMed
38584541Recent Advancements in Refashioning of NSAIDs and their Derivatives as Anticancer Candidates.Curr Pharm Des2024https://conductscience.org/library/papers/38584541PubMed
38165473COX 2-inhibitors; a thorough and updated survey into combinational therapies in cancers.Med Oncol2024https://conductscience.org/library/papers/38165473PubMed
37138287Construction of a lipid metabolism-related and immune-associated prognostic score for gastric cancer.BMC Med Genomics2023https://conductscience.org/library/papers/37138287PubMed
36361772Valdecoxib Protects against Cell Apoptosis Induced by Endoplasmic Reticulum Stress via the Inhibition of PERK-ATF4-CHOP Pathway in Experimental Glaucoma.Int J Mol Sci2022https://conductscience.org/library/papers/36361772PubMed
35450217The Association Between Cyclooxygenase-2 -1195G/A (rs689466) Gene Polymorphism and the Clinicopathology of Lung Cancer in the Japanese Population: A Case-Controlled Study.Front Genet2022https://conductscience.org/library/papers/35450217PubMed
35008687Pros and Cons of Pharmacological Manipulation of cGMP-PDEs in the Prevention and Treatment of Breast Cancer.Int J Mol Sci2021https://conductscience.org/library/papers/35008687PubMed
34640461A Systematic Review of the Cyclooxygenase-2 (COX-2) Expression in Rectal Cancer Patients Treated with Preoperative Radiotherapy or Radiochemotherapy.J Clin Med2021https://conductscience.org/library/papers/34640461PubMed
34529222Modulation of endothelium function by fatty acids.Mol Cell Biochem2022https://conductscience.org/library/papers/34529222PubMed
34351578Interactions between exposure to polycyclic aromatic hydrocarbons and xenobiotic metabolism genes, and risk of breast cancer.Breast Cancer2022https://conductscience.org/library/papers/34351578PubMed
34178680The Inflammatory Profile of the Tumor Microenvironment, Orchestrated by Cyclooxygenase-2, Promotes Epithelial-Mesenchymal Transition.Front Oncol2021https://conductscience.org/library/papers/34178680PubMed
33972599Cyclooxygenase-2 induces neoplastic transformation by inhibiting p53-dependent oncogene-induced senescence.Sci Rep2021https://conductscience.org/library/papers/33972599PubMed

See all 231 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
MT-CO24513PubTator's text mininghttps://conductscience.org/library/genes/4513NCBI Gene
PTGS25743PubTator's text mininghttps://conductscience.org/library/genes/5743NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11278747

GET https://conductscience.org/api/papers/v1/11278747/cited_by?page=2